Richard A. Heyman - 24 Jul 2026 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Reporting relationship: Director
Issuer ticker: ORIC
Reported as of: 24 Jul 2026
Net transaction value: -$157,462
SEC form: 4
Accepted by SEC: 28 Jul 2026, 16:15:14 UTC
Prior SEC filing: 08 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Kuhlen, attorney-in-fact

Key filing fact

Richard A. Heyman filed Form 4 for Oric Pharmaceuticals, Inc. (ORIC) on 28 Jul 2026.

Key facts

This page summarizes Richard A. Heyman's Form 4 filing for Oric Pharmaceuticals, Inc. (ORIC).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Jul 2026, 16:15.

Change

Previous filing in this sequence was filed on 08 Jul 2026.
Current net transaction value: -$157,462.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001584759 Primary reporting owner

Heyman Richard A.

Relationship: Director
Address: C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Christian Kuhlen, attorney-in-fact
Signature date: 28 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORIC transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,500
Change %: +8.4%
Price: $1.60^*
Shares after: 45,300
Date: 24 Jul 2026
Ownership: Direct

ORIC transaction

Common Stock

Sale

Transaction value: $84,140
Shares: -7,000
Change %: -15%
Price: $12.02
Shares after: 38,300
Date: 24 Jul 2026
Ownership: Direct
Footnotes: F1

ORIC transaction

Common Stock

Sale

Transaction value: $73,322
Shares: -6,100
Change %: -2.9%
Price: $12.02
Shares after: 206,672
Date: 24 Jul 2026
Ownership: See footnote
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORIC transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -3,500
Change %: -10%
Price: $0.000000^*
Shares after: 30,200
Date: 24 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,500
Exercise price: $1.60
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.

Footnote F2

The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

Footnote F3

The shares subject to the option are fully vested and immediately exercisable.